Eklipo

Eklipo combines ezetimibe and rosuvastatin calcium for cholesterol management. This oral medication supports cardiovascular health by reducing LDL cholesterol levels.

Eklipo is primarily used to lower LDL cholesterol and triglycerides in the blood. It is often prescribed for individuals with high cholesterol who require combination therapy. The medication works by inhibiting cholesterol absorption in the intestines and increasing the liver's ability to break down LDL cholesterol. Eklipo may also be used to manage certain conditions related to high cholesterol, such as atherosclerosis.

Common effects of Eklipo may include headaches, muscle pain, and digestive issues. Some users may experience dizziness or fatigue. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Eklipo should be used with caution in individuals with liver or kidney disease. Regular monitoring of liver function is recommended. Pregnant or breastfeeding women should consult a healthcare provider before using this medication. Always follow the prescribed dosage and instructions provided by a healthcare professional.

Eklipo may interact with certain medications, including other cholesterol-lowering drugs, fibrates, and some antibiotics. Alcohol consumption should be limited while using Eklipo, as it may increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.